Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses. - Wikidata - awgldk - TriplyDB

Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses.

Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses.

http://www.wikidata.org/entity/Q37710227

about

Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple Centers MSC therapy attenuates obliterative bronchiolitis after murine bone marrow transplant A Distinct Subpopulation of Bone Marrow Mesenchymal Stem Cells, Muse Cells, Directly Commit to the Replacement of Liver Components.ST2: the biomarker at the heart of GVHD severity A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo.Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.Epigallocatechin-3-gallate Protects against Hydrogen Peroxide-Induced Inhibition of Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells Recent advances on cellular therapies and immune modulators for graft-versus-host disease.Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review.Adipose Stem Cell Therapy Mitigates Chronic Pancreatitis via Differentiation into Acinar-like Cells in Mice.Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization.Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke.Remestemcel-L for the treatment of graft versus host disease.Mesenchymal stem cells and their immunosuppressive role in transplantation tolerance.Immunosuppressive Mesenchymal Stromal Cells Derived from Human-Induced Pluripotent Stem Cells Induce Human Regulatory T Cells In Vitro and In Vivo.Hypoxic Preconditioning Combined with Microbubble-Mediated Ultrasound Effect on MSCs Promote SDF-1/CXCR4 Expression and its Migration Ability: An In Vitro Study.The predictive value of selected serum microRNAs for acute GVHD by TaqMan MicroRNA arrays.Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.Comparison of human bone marrow stromal cells cultured in human platelet growth factors and fetal bovine serum.Isolation and Manufacture of Clinical-Grade Bone Marrow-Derived Human Mesenchymal Stromal Cells.Integrated culture platform based on a human platelet lysate supplement for the isolation and scalable manufacturing of umbilical cord matrix-derived mesenchymal stem/stromal cells.Mesenchymal Stromal Cells in Hematopoietic Stem Cell Transplantation.New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic Review Immune Regulation in Hematopoietic Cell Transplantation

P2860

Q28067094-3A80644D-ADBA-4EC3-9627-984A73A75793 Q33608418-35B0615D-3BC8-4BBA-A2D6-8230E1185D67 Q34278561-32B6D823-80CA-406D-A227-31177C934D2B Q34504983-0E1D685D-B946-4D24-9C10-2D58B516172B Q34802351-CC7C2D2A-D6C1-498F-850F-E935312BDD89 Q34979619-AA43B1CC-3AB9-4C31-AEA1-A12548BF4799 Q35022269-553295B9-A763-4510-89FE-14B9A63C74D6 Q35224328-8707E7EC-68C7-4A6A-A4B9-54D3DA71F7BD Q36202472-2D53D1F5-798E-4C77-9F35-57DFC5805B06 Q36605387-BED96A74-D535-44A9-AA0D-28653507DE8A Q38246755-36B87A6C-AD64-4E9F-A595-7986E15B09E1 Q38393820-54FBE85F-89D1-4A4D-8694-11AB9F4F64AC Q38636311-E77396B3-D0A6-49E7-9E33-3D8550D84193 Q38682125-568F15B2-5EBD-4905-A4CD-EAD14D3CB188 Q38742380-BA480E49-7B2D-4872-852A-C3DAB979A886 Q38892351-607AD9A9-B315-45C6-8B0D-65BBB3077E17 Q39430866-D3D32063-454A-44FA-BFA6-F38F9958F9D7 Q49289725-E8F9E8D4-8B44-43A2-987C-2F7236FE54B1 Q51513152-70A72B9F-9C8B-473F-90BE-1C384670AE3E Q51555000-AD4393E0-335F-45CD-ADC9-FB9E83B6B46E Q52667946-545C624B-3DBC-434B-B216-F1A3816EBAA6 Q52726579-533B8ADA-23F8-48DE-911F-50181A863DB4 Q52866935-D5DD7375-C888-4119-9EA6-269AD846662D Q53063065-F637FEF4-AFC9-4F0A-AF9B-E33F6D6E80A5 Q53092701-E41C1B47-B881-46CC-9697-BAD4574898F9 Q57176906-50BBC5A8-FFDA-4E8A-BCE8-D77B818FEDFE Q57538743-A711EED3-496F-4428-A393-8401EE1FB29B Q58415034-C3032492-CCEE-4153-8898-AEEC110A4B34

P2860

Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses.

http://www.wikidata.org/entity/Q37710227

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bone marrow mesenchymal stroma ...... rkers with clinical responses.

@en

Bone marrow mesenchymal stroma ...... rkers with clinical responses.

@nl

type

label

Bone marrow mesenchymal stroma ...... rkers with clinical responses.

@en

Bone marrow mesenchymal stroma ...... rkers with clinical responses.

@nl

prefLabel

Bone marrow mesenchymal stroma ...... rkers with clinical responses.

@en

Bone marrow mesenchymal stroma ...... rkers with clinical responses.

@nl

P1433

Q37710227-D0A136E1-2D51-4A90-BC5D-8F859848DAB5

P1476

Q37710227-71C132A0-71CA-465A-BBA3-BA0995C96837

P2093

Q37710227-2601C999-EA80-43FA-A7E6-12DAB29ECA52

Q37710227-28239EFE-9A79-4ABA-A350-E9BC8122DA7F

Q37710227-53B8CAE9-9DD5-4471-BD6A-D94DA7F5CDBD

Q37710227-685FEDE5-CEA0-4427-A4C0-20D85C7C403C

Q37710227-6DF94143-51FE-465F-BF7B-BF41D8118EFA

Q37710227-71EA1AFD-68FB-4E57-B701-C6371CAC5DA1

Q37710227-7A78C256-AFAA-4D95-B654-4D400E7A5560

Q37710227-93BAF7BD-66F5-48B6-910B-E110C58D83C1

Q37710227-A046B635-EC52-440B-A6DA-6BA1C9CCBE39

Q37710227-ADA4D512-A0DF-4802-B882-F71D85FCEFC7

P2860

Q37710227-18220CF6-0B46-4C33-B0C1-8A9E1F550EA3

Q37710227-1C522404-0432-4B88-A7CB-54B13784BFC9

Q37710227-52E51D52-7A98-43D6-83F0-0A4318884BE7

Q37710227-5A18AEAA-1CEB-460B-8F41-4DAD1B4BA3CA

Q37710227-5EAC8687-E26E-4D7B-93CC-6534D0CF4E23

Q37710227-65CB0B15-37CC-4FEA-918C-DCF960D66A4E

Q37710227-68A449CD-F19F-401F-A25E-DD843CFCF2F1

Q37710227-72232D3D-C713-48D5-8446-9A541E972F26

Q37710227-80C07644-793D-4D12-A697-6E9FC12A655A

Q37710227-9F3E03F5-A7A4-4683-A899-F24AEE947C97

P304

Q37710227-F7A195B4-EF71-4EAB-9A24-61C64C23FD6D

P31

Q37710227-FDB3C9C4-1B3D-49F4-B75E-6F23FF4BF5F8

P356

Q37710227-96BED148-354D-4176-8076-276B4CB253F0

P433

Q37710227-4985F8E1-F82B-476C-9703-A0EF20FFEF0F

P478

Q37710227-8AFFED99-4369-454F-954F-44CD0C7827C1

P50

Q37710227-553ABF8D-1D4B-41F1-AFBF-6C6424542689

P577

Q37710227-736DB0A0-A00F-4B8C-A3BE-D13958A6A854

P5875

Q37710227-48D0D6BE-B5F5-4C2C-98B2-7434622FC1E5

P698

Q37710227-7B40C25C-E350-41E5-BEF5-B8E45E2372F8

P921

Q37710227-32E4D5C1-7054-41E9-A420-5419DC946B70

P932

Q37710227-5F8A1991-0F83-4644-A838-0C8E0D0992B1

P356

P1433

P1476

Bone marrow mesenchymal stroma ...... arkers with clinical responses

@en

P2093

A John Barrett

http://www.w3.org/2001/XMLSchema#string

David Stroncek

http://www.w3.org/2001/XMLSchema#string

Eleftheria Koklanaris

http://www.w3.org/2001/XMLSchema#string

Fang Yin

http://www.w3.org/2001/XMLSchema#string

Fariba Chinian

http://www.w3.org/2001/XMLSchema#string

Jan Joseph Melenhorst

http://www.w3.org/2001/XMLSchema#string

Jeffrey Klotz

http://www.w3.org/2001/XMLSchema#string

Leigh Samsel

http://www.w3.org/2001/XMLSchema#string

Marianna Sabatino

http://www.w3.org/2001/XMLSchema#string

Minoo Battiwalla

http://www.w3.org/2001/XMLSchema#string

P2860

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

The establishment of a bank of stored clinical bone marrow stromal cell products.

Steroid-Refractory Acute GVHD: Predictors and Outcomes.

Plasma biomarkers of lower gastrointestinal and liver acute GVHD.

Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study.

Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation.

Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency.

Discovery and validation of graft-versus-host disease biomarkers

HSCT recipients have specific tolerance to MSC but not to the MSC donor

P304

1278-1288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/STEM.1638

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259877952

http://www.w3.org/2001/XMLSchema#string

P698

24452962

http://www.w3.org/2001/XMLSchema#string

P921

P932

3991733

http://www.w3.org/2001/XMLSchema#string